Exicure (XCUR) Cash from Operations (2016 - 2026)
Exicure's (XCUR) quarterly Cash from Operations came in at 1142000.0 in Q1 2026, up 28.54% YoY from 888469.33 in Q1 2025, and little changed on a QoQ basis from 1147000.0 in Q4 2025.
Exicure (XCUR) Cash from Operations (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 11 years of Cash from Operations data on file, last reported at 1142000.0 in Q1 2026.
- Quarterly Cash from Operations rose 28.54% year-over-year to 1142000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8099000.0 (down 99.58% YoY) and the FY2025 annual result came in at 8555000.0, down 193.99% from the prior year.
- Cash from Operations held at 1142000.0 in Q1 2026, from 1147000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 449000.0 in Q3 2024 to a low of 12756000.0 in Q1 2022.
- A 5-year average of 3448352.94 and a median of 1598000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 88.79% — and 2025, when it plunged 685.75%.
- Tracing XCUR's Cash from Operations over 5 years: stood at 7276000.0 in 2022, then surged by 88.79% to 816000.0 in 2023, then dropped by 3.55% to 845000.0 in 2024, then slumped by 35.74% to 1147000.0 in 2025, then increased by 0.44% to 1142000.0 in 2026.
- The last three Cash from Operations figures came in at 1142000.0 (Q1 2026), 1147000.0 (Q4 2025), and 3528000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - | -887,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14 Mn |
| Mar 31, 2026 | -1.14 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | -3.53 Mn |
| Sep 30, 2025 | -3.53 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -845,000.00 |
| Dec 31, 2024 | -845,000.00 |
| Sep 30, 2024 | -449,000.00 |
| Sep 30, 2024 | -449,000.00 |
| Jun 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -450,000.00 |
| Mar 31, 2024 | -450,000.00 |
| Dec 31, 2023 | -816,000.00 |
| Dec 31, 2023 | -816,000.00 |